Future relevance of genetic testing: A systematic horizon scanning analysis

International Journal of Technology Assessment in Health Care

Volumn 23, Issue 4, 2007, Pages 495-504

  Storz, Philipp ^a   Kolpatzik, Kai ^b   Perleth, Matthias ^c   Klein, Silvia ^a   Häussler, Bertram ^d  

^a IGES (Institute for Health and Social Research)   (Germany)

^b Federal Association of the Local Health Insurance Funds   (Germany)

^c Federal Joint Committee/G BA ^*  (Germany)

^d TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Bibliographic databases; Biomedical technology assessment; Genetic techniques; Research priorities

Indexed keywords

BIBLIOGRAPHIC DATABASES; BIOMEDICAL TECHNOLOGY ASSESSMENT; GENETIC TECHNIQUES; RESEARCH PRIORITIES;

BIOLOGICAL ORGANS; DATABASE SYSTEMS; GERMANY; HEALTH CARE; INNOVATION; INTERNET;

DISEASES;

ANALYSIS; ARTICLE; BEHAVIOR DISORDER; CARDIOVASCULAR DISEASE; DATA BASE; ENDOCRINE DISEASE; GENETIC ANALYSIS; HORIZON SCANNING ANALYSIS; INTERNET; MENTAL DISEASE; METABOLIC DISORDER; NEOPLASM; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; PHARMACOGENETICS; RESEARCH; SCREENING; TECHNOLOGY;

DATABASES, BIBLIOGRAPHIC; GENETIC DISEASES, INBORN; GENETIC SCREENING; GERMANY; HUMANS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 35348914251     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462307070596     Document Type: Article

References (17)

1. Brown IT, Smale A, Momandwall V, Momandwall S. Medical technology horizon scanning. Australas Phys Eng Sci Med. 2005;28:200-203.
2. Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomics research. A blueprint for the genomic era. Nature. 2003;422:835-847.
3. Douw K, Vondeling H, Eskildsen D, Simpson S. Use of the internet in scanning the horizon for new and emerging health technologies: A survey of agencies involved in horizon scanning. J Med Internet Res. 2003;5:e6.
4. Douw K, Vondeling H, Oortwijn W. Priority setting for horizon scanning of new health technologies in Denmark: Views of health care stakeholders and health economists. Health Policy. 2006;76:334-345.
5. Douw K, Vondeling H, Sǿrensen J, Jǿrgensen T, Sigmund H. "The future should not take us by surprise": Preparation of an early warning system in Denmark. Int J Technol Assess Health Care. 2004;20:342-350.
6. Douw K, Vondeling H. Selection of new health technologies for assessment aimed at informing decision making: A survey among horizon scanning systems. Int J Technol Assess Health Care. 2006;22:177-183.
7. Evans A, Van Baal GC, McCarron P, et al. The genetics of coronary heart disease: The contribution of twin studies. Twin Res. 2003;6:432-441.
8. Fierz W. Challenge of personalized health care: To what extent is medicine already individualized and what are the future trends? Med Sci Monit. 2004;10:RA111-RA123.
9. Giacomini M, Miller F, Browman G. Confronting the "gray zones" of technology assessment: Evaluating genetic testing services for public insurance coverage in Canada. Int J Technol Assess Health Care. 2003;19:301-316.
10. Hall WD, Morley KI, Lucke JC. The prediction of disease risk in genomic medicine. Scientific prospects an implications for public policy and ethics. EMBO Rep. 2004;5:S22-S26.
11. Higashi MK, Veenstra DL. Managed care in the genomics era: Assessing the cost effectiveness of genetic tests. Am J Manag Care. 2003;9:493-500.
12. Langer T, Wild C, Douw K. Overview on Horizon Scanning System (HSS) for Priority Setting on emerging/new technologies. Ludwig Boltzmann Institute LBI-HTA Projektbericht Nr.: 002 (EUNetHTA WP7 Strand B - 1 Deliverable). 2006.
13. Mundy L, Merlin TL, Parrella A. The Australia and New Zealand horizon scanning network. Aust Health Rev. 2005;29:395-397.
14. Robert G, Stevens A, Gabbay J. 'Early warning systems' for identifying new healthcare technologies. Health Technol Assess. 1999;3.
15. Rogowski W. Genetic Screening by DNA technology: A systematic review of health economic evidence. Int J Technol Assess Health Care. 2006;22:327-337.
16. Simpson S, Hyde C, Cook A, Packer C, Stevens A. Assessing the accuracy of forecasting: Applying standard diagnostic assessment tools to a health technology early warning system. Int J Technol Assess Health Care. 2004;20:381-384.
17. Van Delden J, Bold I, Kalis A, Derijks J, Leufkens H. Tailor-made pharmacotherapy: Future developments and ethical challenges in the field of pharmacogenomics. Bioethics. 2004;18:303-321.